Distributor of accriva products for (b)(4) reported a lower than expected act result with a hemochron signature elite and act+ microcoagulation system.During an unspecified procedure in the cath lab, the patient reportedly received an unspecified bolus dose of heparin with a target act of 300 seconds.The patient's initials, age, gender and weight were not specified.The type of procedure, act draw time(s) and results, concomitant medications and clinical circumstances of the case are unknown at the time of this report; however, this information has been requested.
|